PlainRecalls
FDA Drug Moderate Class II Ongoing

Moxifloxacin 4 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for Intraocular Injection, Rx only, Imprimis NJOF, LLC. 1705 Route 46 West, unit 6B, Ledgewood, NJ 07852, NDC 71384-511-08

Reported: June 5, 2024 Initiated: May 14, 2024 #D-0516-2024

Product Description

Moxifloxacin 4 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for Intraocular Injection, Rx only, Imprimis NJOF, LLC. 1705 Route 46 West, unit 6B, Ledgewood, NJ 07852, NDC 71384-511-08

Reason for Recall

Lack of Assurance of Sterility

Details

Recalling Firm
Imprimis NJOF, LLC
Units Affected
165,920 vials
Distribution
Nationwide within the United States
Location
Ledgewood, NJ

Frequently Asked Questions

What product was recalled?
Moxifloxacin 4 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for Intraocular Injection, Rx only, Imprimis NJOF, LLC. 1705 Route 46 West, unit 6B, Ledgewood, NJ 07852, NDC 71384-511-08. Recalled by Imprimis NJOF, LLC. Units affected: 165,920 vials.
Why was this product recalled?
Lack of Assurance of Sterility
Which agency issued this recall?
This recall was issued by the FDA Drug on June 5, 2024. Severity: Moderate. Recall number: D-0516-2024.